(Q46066318)

19 December 2017

title

Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety (English)

1 reference

19 December 2017

1 reference

F de Zegher

1

1 reference

19 December 2017

L Ibáñez

series ordinal

2

1 reference

19 December 2017

publication date

1 January 2009

1 reference

19 December 2017

Journal of Endocrinological Investigation

published in

1 reference

19 December 2017

volume

32

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

83-84

1 reference

19 December 2017

Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Clinical practice. Hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Long-term safety and tolerability of flutamide for the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

21 January 2018

Flutamide Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Long-Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345685

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer

21 January 2018

1 reference

12 December 2020

Fatal liver complications with flutamide

1 reference

12 December 2020

Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior

1 reference

12 December 2020

A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism

1 reference

12 December 2020

Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)

1 reference

12 December 2020

Comparison of finasteride versus flutamide in the treatment of hirsutism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345685

1 reference

19 December 2017

1 reference

19 December 2017